 Discharge on once a day degludec insulin by pen supplied by Novo at dose 0.3 Ukg with reduction to 0.2 Ukg for GFR 30 mlhr. Degludec insulin will be started at study initiation during the hospitalization if the participant is randomized to this arm. 